Cell-based regenerative medicine for renovascular disease

Area of Science:

• Nephrology
• Regenerative Medicine
• Cardiovascular Research

Background:

• Renal artery stenosis (RAS) leads to hypertension and kidney damage.
• Damage involves intrarenal microvascular rarefaction, tubular injury, and fibrosis.
• Kidney parenchyma is a key therapeutic target.

Purpose of the Study:

• To review regenerative approaches for kidney repair in RAS.
• To highlight the potential of mesenchymal stem/stromal cells (MSCs) in treating RAS-induced kidney damage.

Main Methods:

• Review of experimental models and clinical studies on regenerative therapies for RAS.
• Focus on cell-based therapies, particularly MSCs.

Main Results:

• Regenerative approaches have shown success in experimental RAS models.
• MSC delivery in human subjects with RAS yielded promising results for kidney repair.

Conclusions:

• Intrinsic kidney pathways contribute to irreversible damage in RAS.
• Regenerative medicine, especially MSCs, offers a promising therapeutic avenue.
• Further validation is needed for routine clinical application in averting kidney damage.